Eradication of Helicobacter pylori infection. ?????????? ?????? ?? ????? ???? ?????? ?? ?? ?? ??? ??? ???? ???? ???? ?? ???
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chronic gastritis with or without improved PUD caused by Helicobacter pylori Helicobacter pylori (+) determined by any of the rapid urease test and histopathology, urease breath test, fecal antigen test Patients who have not received Helicobacter pylori eradication treatment
Exclusion criteria
Exclusion criteria: Allergy to the drugs used in the study Use of PPIs, H2 receptor antagonists, antibiotics, bismuth or probiotics in the last 4 weeks before entering the study Smoking and alcohol abuse The presence of underlying disease or conditions such as liver disease, cardiovascular disease, lung disease, metabolic disease, or malignant tumor that may affect the study Pregnant or lactating female patients Performing esophageal or gastric surgery procedures in the past Incomplete follow-up or low acceptance capacity of patients in treatment during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori infection. Timepoint: 4 weeks after receiving two treatment regimens, the eradication rate of Helicobacter pylori in two groups is compared. Method of measurement: Laboratory method of testing Helicobacter pylori antigen in stool. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences